Colorectal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 18 and 80 years old, of any sex
- People who have been diagnosed with rectal cancer (a specific type called adenocarcinoma), confirmed by a biopsy, and whose tumour has been tested and shown to have a particular molecular profile called pMMR/MSS
- People whose tumour is located close to the opening of the back passage (within 5 cm of the anal verge, as measured by examination or scan)
- People whose cancer is at an early-to-moderate stage, has not spread to distant parts of the body, and meets a specific set of scan-based measurements — including tumour size, the extent it wraps around the bowel wall, nearby lymph node size, and clearance from surrounding tissue (confirm with trial site for full details)
- People whose tumour shrank by at least 30% in length on MRI scans after receiving at least two cycles of a chemotherapy combination called XELOX
- People who have completed a full course of combined treatment before surgery, including a longer course of radiation with chemotherapy, followed by additional chemotherapy cycles (confirm with trial site for exact cycle numbers)
- People joining the prospective part of the study who have signed a written consent form agreeing to take part
Who may not be able to join:
- People who have had another type of cancer in the past, or who currently have another cancer, unless it was a fully cured skin cancer (basal cell carcinoma) or a non-invasive cervical condition (carcinoma in situ)
- People whose medical records are too incomplete for the trial team to properly assess their case
- People joining the prospective part of the study who are not willing to sign a written consent form
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 18980602028
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
1-year organ preservation rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.